SCHEMBL7694033

SCHEMBL7694033

O=C(NCc1cccc(-c2ccccc2)c1)C1CCC(Nc2nc3ccccc3[nH]2)CC1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.55
RAB9A P51151 3/20 0.50
NPC1 O15118 2/20 0.50
POLB P06746 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 2/20 0.47
ITGB3 P05106 2/20 0.45
ITGAV P06756 2/20 0.45
GID4 Q8IVV7 1/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPK1 P28482 2/20 0.43
HSD17B10 Q99714 1/20 0.43
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7691415 1.00 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7694028 1.00 SMN1; SMN2 (0.55) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7085654 0.91 SMN1; SMN2 (0.59) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7089468 0.91 SMN1; SMN2 (0.59) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7085647 0.91 SMN1; SMN2 (0.59) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7696283 0.89 MAPT (0.54) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7698815 0.89 MAPT (0.54) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7695794 0.89 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7695789 0.89 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1POLBTDP1
SCHEMBL7691968 0.89 SMN1; SMN2 (0.52) SMN1; SMN2RAB9ANPC1POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US claimed
US-6380205-B1 QUINAZOLINE THROUGH A C1-C4ALKYL, C1- C4ALKENYL, C1-C4ALKYNYL, C1-C4ALKOXY, AMINO, AMINOC1-C4ALKYL, HYDROXYC1-C4ALKYL, CARBONYL, CYCLOC3-C6ALKYL OR AMINOCARBONYL CHAIN, USEFUL FOR TREATMENT OF THE PAIN MERCK & CO., INC. 2002-04-30 US disclosed
US-6291499-B1 TREATING MIGRAINE, DEPRESSION, ANXIETY, SCHIZOPHRENIA, PARKINSON'S DISEASE, OR STROKE MERCK & CO., INC. 2001-09-18 US disclosed